Literature DB >> 8880125

Role of interleukin-6 in skeletal muscle protein breakdown and cathepsin activity in vivo.

J Fujita1, T Tsujinaka, C Ebisui, M Yano, H Shiozaki, A Katsume, Y Ohsugi, M Monden.   

Abstract

In order to elucidate the acute and chronic effects of interleukin-6 (IL-6) on muscle protein degradation, the weight of skeletal muscles and the activities of lysosomal cathepsins (B and L) in the muscles were examined in two animal models. Two intraperitoneal injections of recombinant human IL-6 into rats did neither significantly affect the cathepsin activities in the soleus and the extensor digitorum longus muscles nor the weight of these muscles. On the other hand, the gastrocnemius muscles of the IL-6 transgenic mice underwent severe atrophy accompanied by a marked increase in cathepsin activities. We conclude that IL-6 mediates muscle protein degradation with enhancing lysosomal cathepsin activity, and that these muscle reactions are mandated by chronic exposure to a high level of IL-6.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880125     DOI: 10.1159/000129477

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  12 in total

1.  Angiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production.

Authors:  Peter M Abadir; Jeremy D Walston; Robert M Carey; Helmy M Siragy
Journal:  J Interferon Cytokine Res       Date:  2011-02-02       Impact factor: 2.607

2.  The frail renin-angiotensin system.

Authors:  Peter M Abadir
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

Review 3.  Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction.

Authors:  Bharathi Upadhya; Mark J Haykowsky; Joel Eggebeen; Dalane W Kitzman
Journal:  Curr Heart Fail Rep       Date:  2015-06

4.  TNF-α, IFN-γ, IL-10, and IL-4 levels were elevated in a murine model of human sickle cell anemia maintained on a high protein/calorie diet.

Authors:  Hyacinth I Hyacinth; Patrice L Capers; David R Archer; Jacqueline M Hibbert
Journal:  Exp Biol Med (Maywood)       Date:  2013-11-26

5.  Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons.

Authors:  Charles P Lambert; Nicole R Wright; Brian N Finck; Dennis T Villareal
Journal:  J Appl Physiol (1985)       Date:  2008-06-05

Review 6.  Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.

Authors:  Tadashi Yoshida; A Michael Tabony; Sarah Galvez; William E Mitch; Yusuke Higashi; Sergiy Sukhanov; Patrice Delafontaine
Journal:  Int J Biochem Cell Biol       Date:  2013-06-13       Impact factor: 5.085

7.  IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting.

Authors:  Liping Zhang; Jie Du; Zhaoyong Hu; Guofeng Han; Patrice Delafontaine; Gabriela Garcia; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 10.121

8.  The translation inhibitor pateamine A prevents cachexia-induced muscle wasting in mice.

Authors:  Sergio Di Marco; Anne Cammas; Xian Jin Lian; Erzsebet Nagy Kovacs; Jennifer F Ma; Derek T Hall; Rachid Mazroui; John Richardson; Jerry Pelletier; Imed Eddine Gallouzi
Journal:  Nat Commun       Date:  2012-06-12       Impact factor: 14.919

9.  Effects of arachidonic acid supplementation on training adaptations in resistance-trained males.

Authors:  Michael D Roberts; Mike Iosia; Chad M Kerksick; Lem W Taylor; Bill Campbell; Colin D Wilborn; Travis Harvey; Matthew Cooke; Chris Rasmussen; Mike Greenwood; Ronald Wilson; Jean Jitomir; Darryn Willoughby; Richard B Kreider
Journal:  J Int Soc Sports Nutr       Date:  2007-11-28       Impact factor: 5.150

Review 10.  Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.

Authors:  T Scott Bowen; Gerhard Schuler; Volker Adams
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-06-03       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.